Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.
Alejandra DarlingCristina TelloMaría Josep MartíCristina GarridoSergio Aguilera-AlbesaMiguel Tomás VilaItziar GastónMarcos MadrugaLuis González GutiérrezJulio Ramos LizanaMontserrat PujolTania Gavilán IglesiasKylee TustinJean Pierre LinGiovanna ZorziNardo NardocciLoreto MartorellGustavo Lorenzo SanzFuencisla GutiérrezPedro J GarcíaLidia VelaCarlos Hernández LahozJuan Darío Ortigoza EscobarLaura Martí SánchezFradique MoreiraMiguel CoelhoLeonor Correia GuedesAna Castro CaldasJoaquim FerreiraPaula PiresCristina CostaPaulo RegoMarina MagalhãesMaría StamelouDaniel Cuadras PallejàCarmen Rodríguez-BlazquezPablo Martínez-MartínVincenzo LupoLeonidas StefanisRoser PonsCarmen EspinósTeresa TemudoBelén Pérez DueñasPublished in: Movement disorders : official journal of the Movement Disorder Society (2017)
The proposed scale seems to be a reliable and valid instrument for the assessment of pediatric and adult patients with pantothenate kinase-associated neurodegeneration. Additional validation studies with a larger sample size will be required to confirm the present results and to complete the scale validation testing. © 2017 International Parkinson and Movement Disorder Society.